LAUREN AZUELA: Open Payments
NPI 1487152054 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 40 payments from 7 companies in 2025. Trend: 2023 $1,139 · 2024 $708 · 2025 $957
Food & beverage: $951Education: $5
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $439 |
| Janssen Pharmaceuticals, Inc | 9 | $185 |
| Vanda Pharmaceuticals Inc. | 7 | $143 |
| E.R. Squibb & Sons, L.L.C. | 2 | $76 |
| ABBVIE INC. | 2 | $50 |
| Alkermes, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: ABILIFY ASIMTUFII, INVEGA SUSTENNA, FANAPT, ABILIFY MAINTENA, COBENFY, VRAYLAR, ARISTADA, UZEDY.
Industry payments across CA — which companies pay providers there.
